Medicare may have paid up to $105 million for questionable vascular procedures in 2023 alone, according to a new OIG report. No accusations have been made at this time, but the government thinks 139 different physicians deserve "further scrutiny." Medicare may have paid up to $105 million for questionable vascular procedures in 2023 alone, according to a new OIG report. No accusations have been made at this time, but the government thinks 139 different physicians deserve "further scrutiny." | | |
|
Drinking a lot of coffee may increase a person's heart attack risk, according to a new meta-analysis. On the other hand, coffee intake was linked to key benefits in the same study. Drinking a lot of coffee may increase a person's heart attack risk, according to a new meta-analysis. On the other hand, coffee intake was linked to key benefits in the same study. | | |
|
The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. | | |
|
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context. A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context. | | |
|
The Edwards Lifesciences Triformis Resilia is the first dedicated surgical tricuspid valve on the market cleared with data from off-label use of mitral valves. The Edwards Lifesciences Triformis Resilia is the first dedicated surgical tricuspid valve on the market cleared with data from off-label use of mitral valves. | | |
|
FFR-CT literature has reached a state of maturity where experts can comfortably start to provide guidelines to the wider community. FFR-CT literature has reached a state of maturity where experts can comfortably start to provide guidelines to the wider community. | | |
|
Cathie Biga, MSN, a former ACC president, says salary is just one thing a cardiologist should ask about before signing any contract. Cathie Biga, MSN, a former ACC president, says salary is just one thing a cardiologist should ask about before signing any contract. | | |
|
Parmley is most noted for his research on the harmful effects of secondhand smoke, hemodynamics and new therapies for heart failure. Parmley is most noted for his research on the harmful effects of secondhand smoke, hemodynamics and new therapies for heart failure. | | |
|
Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business. Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business. | | |
|
This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected. This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected. | | |
|
The devices were set aside to be scrapped before they were stolen. Now, patients could be using them and not even know it. The devices were set aside to be scrapped before they were stolen. Now, patients could be using them and not even know it. | | |
|
SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation. SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation. | | |
|
The FDA is once again warning the public about a safety issue with certain Impella heart pumps. The FDA is once again warning the public about a safety issue with certain Impella heart pumps. | | |
|
